{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:28:11Z","timestamp":1791106091888,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T00:00:00Z","timestamp":1218585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/npp.2008.127","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T12:55:30Z","timestamp":1218718530000},"page":"899-911","source":"Crossref","is-referenced-by-count":67,"title":["Mechanisms of Withdrawal-Associated Increases in Heroin Self-Administration: Pharmacologic Modulation of Heroin vs Food Choice in Heroin-Dependent Rhesus Monkeys"],"prefix":"10.1038","volume":"34","author":[{"given":"S Stevens","family":"Negus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,13]]},"reference":[{"key":"BFnpp2008127_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(91)90214-B","volume":"193","author":"E Acquas","year":"1991","unstructured":"Acquas E, Carboni E, Di Chiara G (1991). Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharmacol 193: 133\u2013134.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008127_CR2","first-page":"20","volume":"43","author":"GK Aghajanian","year":"1982","unstructured":"Aghajanian GK (1982). Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors. J Clin Psychiatry 43: 20\u201324.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2008127_CR3","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S0376-8716(03)00099-1","volume":"70","author":"NA Ator","year":"2003","unstructured":"Ator NA, Griffiths RR (2003). Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70: S55\u2013S72.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2008127_CR4","first-page":"129","volume":"4","author":"J Blasig","year":"1977","unstructured":"Blasig J, Herz A (1977). Precipitated morphine withdrawal in rats as a tool in opiate research. Curr Dev Psychopharmacol 4: 129\u2013149.","journal-title":"Curr Dev Psychopharmacol"},{"key":"BFnpp2008127_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/sj.npp.1300410","volume":"29","author":"JH Broadbear","year":"2004","unstructured":"Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH (2004). Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys. Neuropsychopharmacology 29: 1112\u20131121.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008127_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0278-5846(98)00039-6","volume":"22","author":"S Brugger","year":"1998","unstructured":"Brugger S, Sanchez R, Brugger AJ, Martinez JA (1998). ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats. Prog Neuropsychopharmacol Biol Psychiatry 22: 775\u2013785.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2008127_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s002130050983","volume":"144","author":"MR Carrera","year":"1999","unstructured":"Carrera MR, Schulteis G, Koob GF (1999). Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone. Psychopharmacology (Berl) 144: 111\u2013120.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008127_CR8","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1523\/JNEUROSCI.0491-06.2006","volume":"26","author":"EH Chartoff","year":"2006","unstructured":"Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon Jr WA (2006). Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci 26: 6450\u20136457.","journal-title":"J Neurosci"},{"key":"BFnpp2008127_CR9","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.neuroscience.2006.11.002","volume":"144","author":"SH Criner","year":"2007","unstructured":"Criner SH, Liu J, Schulteis G (2007). Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence. Neuroscience 144: 1436\u20131446.","journal-title":"Neuroscience"},{"key":"BFnpp2008127_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/35000212","volume":"403","author":"JM Delfs","year":"2000","unstructured":"Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000). Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430\u2013434.","journal-title":"Nature"},{"key":"BFnpp2008127_CR11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0022-3565(25)22845-2","volume":"250","author":"CP France","year":"1989","unstructured":"France CP, Woods JH (1989). Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 250: 937\u2013943.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR12","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1046\/j.1460-9568.2002.02187.x","volume":"16","author":"F Frenois","year":"2002","unstructured":"Frenois F, Cador M, Caille S, Stinus L, Le Moine C (2002). Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377\u20131389.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2008127_CR13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-3565(25)31880-X","volume":"211","author":"VF Gellert","year":"1979","unstructured":"Gellert VF, Holtzman SG (1979). Discriminative stimulus effects of naltrexone in the morphine-dependent rat. J Pharmacol Exp Ther 211: 596\u2013605.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1176\/ajp.136.1.100","volume":"136","author":"MS Gold","year":"1979","unstructured":"Gold MS, Redmond Jr DE, Kleber HD (1979). Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiatry 136: 100\u2013102.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2008127_CR15","first-page":"415","volume-title":"Substance Abuse: A Comprehensive Textbook","author":"RA Greenstein","year":"1997","unstructured":"Greenstein RA, Fudala PJ, O\u2019Brien CP (1997). Alternative pharmacotherapies for opiate addiction. In: Lowinson JH, Ruiz P, Millman RB and Langrod JG (eds). Substance Abuse: A Comprehensive Textbook. Williams and Wilkins: Baltimore. pp 415\u2013425."},{"key":"BFnpp2008127_CR16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(25)06689-X","volume":"27","author":"RR Griffiths","year":"1975","unstructured":"Griffiths RR, Wurster RM, Brady JV (1975). Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. Pharmacol Rev 27: 357\u2013365.","journal-title":"Pharmacol Rev"},{"key":"BFnpp2008127_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1901\/jeab.1981.35-335","volume":"35","author":"RR Griffiths","year":"1981","unstructured":"Griffiths RR, Wurster RM, Brady JV (1981). Choice between food and heroin: effects of morphine, naloxone, and secobarbital. J Exp Anal Behav 35: 335\u2013351.","journal-title":"J Exp Anal Behav"},{"key":"BFnpp2008127_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00008877-199501000-00011","volume":"6","author":"SC Heinrichs","year":"1995","unstructured":"Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L (1995). Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6: 74\u201380.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2008127_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","volume":"115","author":"SR Hursh","year":"2008","unstructured":"Hursh SR, Silberberg A (2008). Economic demand and essential value. Psychol Rev 115: 186\u2013198.","journal-title":"Psychol Rev"},{"key":"BFnpp2008127_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1471-4159.2000.0740199.x","volume":"74","author":"PA Iredale","year":"2000","unstructured":"Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS (2000). Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem 74: 199\u2013208.","journal-title":"J Neurochem"},{"key":"BFnpp2008127_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/archpsyc.1985.01790340041006","volume":"42","author":"DR Jasinski","year":"1985","unstructured":"Jasinski DR, Johnson RE, Kocher TR (1985). Clonidine in morphine withdrawal. Differential effects on signs and symptoms. Arch Gen Psychiatry 42: 1063\u20131066.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2008127_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/BF00180844","volume":"88","author":"JL Katz","year":"1986","unstructured":"Katz JL (1986). Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys. Psychopharmacology (Berl) 88: 392\u2013397.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008127_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neubiorev.2003.11.007","volume":"27","author":"GF Koob","year":"2004","unstructured":"Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A et al (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27: 739\u2013749.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2008127_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97\u2013129.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008127_CR25","first-page":"146","volume":"71","author":"GF Koob","year":"1986","unstructured":"Koob GF, Vaccarino FJ, Amalric M, Bloom FE (1986). Neurochemical substrates for opiate reinforcement. NIDA Res Monogr 71: 146\u2013164.","journal-title":"NIDA Res Monogr"},{"key":"BFnpp2008127_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(89)90229-8","volume":"2","author":"TA Kosten","year":"1989","unstructured":"Kosten TA, Kosten TR (1989). Cocaine abuse and opioid withdrawal. Lancet 2: 165\u2013166.","journal-title":"Lancet"},{"key":"BFnpp2008127_CR27","first-page":"4398","volume":"12","author":"L Lu","year":"2000","unstructured":"Lu L, Liu D, Ceng X, Ma L (2000). Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur J Neurosci 12: 4398\u20134404.","journal-title":"Eur J Neurosci"},{"key":"BFnpp2008127_CR28","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/0028-3908(92)90051-P","volume":"31","author":"R Maldonado","year":"1992","unstructured":"Maldonado R, Negus S, Koob GF (1992a). Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31: 1231\u20131241.","journal-title":"Neuropharmacology"},{"key":"BFnpp2008127_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3565(25)11090-2","volume":"261","author":"R Maldonado","year":"1992","unstructured":"Maldonado R, Stinus L, Gold LH, Koob GF (1992b). Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261: 669\u2013677.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/jpet.103.058917","volume":"308","author":"LR McMahon","year":"2004","unstructured":"McMahon LR, Sell SL, France CP (2004). Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 308: 111\u2013119.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR31","first-page":"82","volume":"185","author":"NK Mello","year":"2005","unstructured":"Mello NK (2005). Fischman Memorial Lecture. Evaluation of drug abuse treatment medications: concordance between clinical and preclinical studies. NIDA Res Monogr 185: 82\u2013104.","journal-title":"NIDA Res Monogr"},{"key":"BFnpp2008127_CR32","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.pbb.2006.11.008","volume":"85","author":"NK Mello","year":"2006","unstructured":"Mello NK, Negus SS, Rice KC, Mendelson JH (2006). Effects of the CRF1 antagonist antalarmin on cocaine self-administration and discrimination in rhesus monkeys. Pharmacol Biochem Behav 85: 744\u2013751.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2008127_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/sj.npp.1300096","volume":"28","author":"SS Negus","year":"2003","unstructured":"Negus SS (2003). Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with D-amphetamine and flupenthixol. Neuropsychopharmacology 28: 919\u2013931.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008127_CR34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00213-004-2133-y","volume":"180","author":"SS Negus","year":"2005","unstructured":"Negus SS (2005). Interactions between the reinforcing effects of cocaine and heroin in a drug-vs-food choice procedure in rhesus monkeys: a dose-addition analysis. Psychopharmacology (Berl) 180: 115\u2013124.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008127_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1124\/jpet.105.095380","volume":"317","author":"SS Negus","year":"2006","unstructured":"Negus SS (2006). Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317: 711\u2013723.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-59745-197-0_11","volume-title":"Opiate Receptors and Antagonists","author":"S. Stevens Negus","year":"2009","unstructured":"Negus SS . Opioid antagonist effects in animal models related to opioid abuse: drug discrimination and drug self-administration. In: Dean R, Bilsky EJ, Negus SS (eds). Opioid Receptors and Antagonists: From Bench to Clinic. Humana Press: New York, NY. (in press)"},{"key":"BFnpp2008127_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1124\/jpet.300.3.1111","volume":"300","author":"SS Negus","year":"2002","unstructured":"Negus SS, Mello NK (2002). Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy. J Pharmacol Exp Ther 300: 1111\u20131121.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.drugalcdep.2004.01.006","volume":"74","author":"SS Negus","year":"2004","unstructured":"Negus SS, Mello NK (2004). Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend 74: 297\u2013309.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2008127_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00213-002-1038-x","volume":"163","author":"SS Negus","year":"2002","unstructured":"Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS (2002). Kappa opioid antagonist effects of the novel kappa antagonist 5\u2032-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Psychopharmacology (Berl) 163: 412\u2013419.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008127_CR40","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/BF02245939","volume":"118","author":"I Nylander","year":"1995","unstructured":"Nylander I, Vlaskovska M, Terenius L (1995). The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology (Berl) 118: 391\u2013400.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008127_CR41","first-page":"607","volume-title":"The Pharmacological Basis of Therapeutics","author":"CP O\u2019Brien","year":"2006","unstructured":"O\u2019Brien CP (2006). Drug addiction and drug abuse. In: Brunton L, Lazo J, Parker K (eds). The Pharmacological Basis of Therapeutics. McGraw-Hill: New York. pp 607\u2013628."},{"key":"BFnpp2008127_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0006-8993(92)90896-H","volume":"584","author":"AK Rattan","year":"1992","unstructured":"Rattan AK, Koo KL, Tejwani GA, Bhargava HN (1992). The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1\u201313) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat. Brain Res 584: 207\u2013212.","journal-title":"Brain Res"},{"key":"BFnpp2008127_CR43","first-page":"25","volume":"43","author":"DE Redmond Jr","year":"1982","unstructured":"Redmond Jr DE, Huang YH (1982). The primate locus coeruleus and effects of clonidine on opiate withdrawal. J Clin Psychiatry 43: 25\u201329.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2008127_CR44","first-page":"1609","volume":"149","author":"MI Rosen","year":"1992","unstructured":"Rosen MI, Wallace EA, Sullivan MC, Stine S, Kosten TR (1992). Use of cocaine to prevent opiate withdrawal. Am J Psychiatry 149: 1609.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2008127_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","volume":"39","author":"RB Rothman","year":"2001","unstructured":"Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32\u201341.","journal-title":"Synapse"},{"key":"BFnpp2008127_CR46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0091-3057(83)90283-6","volume":"18","author":"GJ Schaefer","year":"1983","unstructured":"Schaefer GJ, Michael RP (1983). Morphine withdrawal produces differential effects on the rate of lever-pressing for brain self-stimulation in the hypothalamus and midbrain in rats. Pharmacol Biochem Behav 18: 571\u2013577.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2008127_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0893-133X(98)00036-0","volume":"19","author":"G Schulteis","year":"1998","unstructured":"Schulteis G, Stinus L, Risbrough VB, Koob GF (1998). Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats. Neuropsychopharmacology 19: 406\u2013416.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008127_CR48","first-page":"565","volume-title":"Physiological Pharmacology I","author":"MH Seevers","year":"1963","unstructured":"Seevers MH, Deneau GA (1963). Physiological aspects of tolerance and dependence. In: Root WS and Hofmann FG (eds). Physiological Pharmacology I. Academic Press: New York. pp 565\u2013640."},{"key":"BFnpp2008127_CR49","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1124\/jpet.301.3.1103","volume":"301","author":"SL Sell","year":"2002","unstructured":"Sell SL, France CP (2002). Cocaine and amphetamine attenuate the discriminative stimulus effects of naltrexone in opioid-dependent rhesus monkeys. J Pharmacol Exp Ther 301: 1103\u20131110.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008127_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00008877-200502000-00006","volume":"16","author":"SL Sell","year":"2005","unstructured":"Sell SL, McMahon LR, Koek W, France CP (2005). Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys. Behav Pharmacol 16: 53\u201358.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2008127_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejphar.2007.05.041","volume":"571","author":"KH Skelton","year":"2007","unstructured":"Skelton KH, Oren D, Gutman DA, Easterling K, Holtzman SG, Nemeroff CB et al (2007). The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. Eur J Pharmacol 571: 17\u201324.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008127_CR52","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0091-3057(78)90292-7","volume":"9","author":"SB Sparber","year":"1978","unstructured":"Sparber SB, Meyer DR (1978). Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats. Pharmacol Biochem Behav 9: 319\u2013325.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2008127_CR53","first-page":"5","volume":"15","author":"SDS Spragg","year":"1940","unstructured":"Spragg SDS (1940). Morphine addiction in chimpanzees. Comp Psychol Monogr 15: 5\u2013132.","journal-title":"Comp Psychol Monogr"},{"key":"BFnpp2008127_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.npp.1300487","volume":"30","author":"L Stinus","year":"2005","unstructured":"Stinus L, Cador M, Zorrilla EP, Koob GF (2005). Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30: 90\u201398.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008127_CR55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0306-4522(90)90106-E","volume":"37","author":"L Stinus","year":"1990","unstructured":"Stinus L, Le Moal M, Koob GF (1990). Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37: 767\u2013773.","journal-title":"Neuroscience"},{"key":"BFnpp2008127_CR56","first-page":"447","volume":"36","author":"AL Tatum","year":"1929","unstructured":"Tatum AL, Seevers MH, Collins KH (1929). Morphine addiction and its physiological interpretation based on experimental evidences. J Pharmacol 36: 447\u2013475.","journal-title":"J Pharmacol"},{"key":"BFnpp2008127_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00413045","volume":"5","author":"T Thompson","year":"1964","unstructured":"Thompson T, Schuster CR (1964). Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia 5: 87\u201394.","journal-title":"Psychopharmacologia"},{"key":"BFnpp2008127_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0014-2999(75)90208-3","volume":"30","author":"LF Tseng","year":"1975","unstructured":"Tseng LF, Loh HH, Wei ET (1975). Effects of clonidine on morphine withdrawal signs in the rat. Eur J Pharmacol 30: 93\u201399.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008127_CR59","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.pnpbp.2008.02.004","volume":"32","author":"EJ Van Bockstaele","year":"2008","unstructured":"Van Bockstaele EJ, Qian Y, Sterling RC, Page ME (2008). Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain. Prog Neuropsychopharmacol Biol Psychiatry 32: 1048\u20131056.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp2008127_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.npp.1301438","volume":"33","author":"BM Walker","year":"2008","unstructured":"Walker BM, Koob GF (2008). Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33: 643\u2013652.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008127_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1360-0443.2003.00372.x","volume":"98","author":"SL Walsh","year":"2003","unstructured":"Walsh SL, Strain EC, Bigelow GE (2003). Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans. Addiction 98: 427\u2013439.","journal-title":"Addiction"},{"key":"BFnpp2008127_CR62","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1530-0277.2000.tb04640.x","volume":"24","author":"KL Williams","year":"2000","unstructured":"Williams KL, Woods JH (2000). A behavioral economic analysis of concurrent ethanol- and water-reinforced responding in different preference conditions. Alcohol Clin Exp Res 24: 980\u2013986.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp2008127_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0376-8716(85)90059-6","volume":"14","author":"JH Woods","year":"1985","unstructured":"Woods JH, Gmerek DE (1985). Substitution and primary dependence studies in animals. Drug Alcohol Depend 14: 233\u2013247.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2008127_CR64","first-page":"179","volume":"19","author":"T Yanagita","year":"1978","unstructured":"Yanagita T (1978). Drug dependence studies in laboratory animals. NIDA Res Monogr 19: 179\u2013190.","journal-title":"NIDA Res Monogr"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2008127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008127","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:44:54Z","timestamp":1738331094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2008127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,13]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BFnpp2008127"],"URL":"https:\/\/doi.org\/10.1038\/npp.2008.127","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,13]]}}}